To include your compound in the COVID-19 Resource Center, submit it here.

The Japanese context

Chugai Pharmaceutical Co. Ltd.'s international strategy plays against the backdrop of the history of the national industry and of profound changes in Japanese health care, an understanding of which has to go beyond the conventional Western wisdom that Japanese drug prices drop every two years.

As Chugai President Osamu Nagayama describes the

Read the full 511 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers